Skip to content
healthcare.dev

Everolimus

NDC 70954-775, Everolimus, tablet, for suspension, from ANI Pharmaceuticals, Inc..

Product NDC
70954-775
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA220597
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-775 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS5 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
70954-775-207095407752028 BLISTER PACK in 1 CARTON (70954-775-20) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (70954-775-10)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ed7f01b0-3660-4785-a057-a32eea78d64b

Use it

Look up 70954-775 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-775 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-775. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.